effects of azacitidine on MDS outcome

Azacitidine Prolongs Overall Survival (OS) and Reduces Infections and Hospitalizations in Patients (Pts) with WHO-Defined Acute Myeloid Leukemia (AML) Compared with Conventional Care Regimens (CCR) / Pierre Fenaux; Ghulam J Mufti; Eva Hellström-Lindberg; Valeria Santini; Norbert Gattermann; Guillermo Sanz; Alan F. List; Steven D. Gore; John F Seymour; Jay Backstrom; Linda Zimmerman; David McKenzie; C. L. Beach; and Lewis B. Silverman. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 112:(2008), pp. 3636-3636. (Intervento presentato al convegno American society of hematology).

Azacitidine Prolongs Overall Survival (OS) and Reduces Infections and Hospitalizations in Patients (Pts) with WHO-Defined Acute Myeloid Leukemia (AML) Compared with Conventional Care Regimens (CCR)

SANTINI, VALERIA;
2008

Abstract

effects of azacitidine on MDS outcome
2008
Supplement ASH
American society of hematology
Pierre Fenaux; Ghulam J Mufti; Eva Hellström-Lindberg; Valeria Santini; Norbert Gattermann; Guillermo Sanz; Alan F. List; Steven D. Gore; John F Seymour; Jay Backstrom; Linda Zimmerman; David McKenzie; C. L. Beach; and Lewis B. Silverman
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/349679
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 1
social impact